ArticleLeukemia2013
ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome.
S Schnittger et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
111 papers cite itlatest 60 shown
this paperpooled ittrialcites it